Carrasco AT - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.

Goncalves A, Fabbro M, Lhommé C, Gladieff L, Extra JM, Floquet A, Chaigneau L, Carrasco AT, Viens P. Goncalves A, et al. Among authors: carrasco at. Gynecol Oncol. 2008 Jan;108(1):42-6. doi: 10.1016/j.ygyno.2007.07.057. Epub 2007 Nov 5. Gynecol Oncol. 2008. PMID: 17980406 Clinical Trial.

Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).

Pautier P, Joly F, Kerbrat P, Bougnoux P, Fumoleau P, Petit T, Rixe O, Ringeisen F, Carrasco AT, Lhommé C. Pautier P, et al. Among authors: carrasco at. Gynecol Oncol. 2010 Feb;116(2):157-62. doi: 10.1016/j.ygyno.2009.10.076. Gynecol Oncol. 2010. PMID: 20109725 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters